Moffitt logo

COVID-19 Update: See the latest on our visitor policy here. Learn More

Clinical Trials Search

Clinical Trial 20794

Cancer Type: Cutaneous
Study Type: Treatment
NCT#: NCT04975152

Phase: Phase I
Principal Investigator: Tarhini, Ahmad

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Neoadjuvant Cemiplimab in Stage I-II Merkel Cell Carcinoma: Safety and Biomarker Analysis

Summary

Objective

Treatments

Therapies

Immunotherapy; Surgery

Medications

Cemiplimab (); REGN2810 (Cemiplimab)

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.